ARTICLE | Clinical News
Celtrix data
May 10, 1993 7:00 AM UTC
All the patients had macular hole damage of less than one year duration. They were treated surgically by vitrectomy. The treatment groups received either a low dose of 660 nanograms of BetaKine or the high dose around the edges of the hole during the procedure. ...